Real-World Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study


A real-world multicenter study found Bezlotoxumab was successful at preventing the reoccurrence of Clostridiodes difficile infections. 

Content Information

Content Author: 
Richard L Hengel, Timothy E Ritter, Ramesh V Nathan, Lucinda J Van Anglen, Claudia P Schroeder, Ryan J Dillon, Stephen W Marcella, Kevin W Garey

Content Source: 
Oxford Academic

Content Type: 
News